REALITene is a very unstable compound. Its complex molecule self-arranges into virtually infinite configurations. Furthermore, different patients have been known to react to different molecule configurations at different times in their clinical life. All these factors make REALITene a compound that is really hard to manage. Our drugs confront with this problem in a radical way: REALITene's configuration is not determined in the lab, but is left to the shaping processes enacted by the patient and its surrounding context.